PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
41 hedge funds and large institutions have $7.24M invested in Palvella Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 8 closing their positions.
Holders
41
Holders Change
-5
Holders Change %
-10.87%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$262K |
2 |
2
Squarepoint
New York
|
$26.7K |
3 |
STA
3
Summit Trail Advisors
New York
|
$25.6K |
4 |
4
Prudential Financial
Newark,
New Jersey
|
$40.5K |
5 |
5
UBS Group
Zurich,
Switzerland
|
$9.52K |